Nucleic Acid Therapy Accelerator
Advancing the development of nucleic acid therapies through high-quality science, interdisciplinary collaborations and translational research.
Get involved
Partnership is at the core of the NATA model — the successful delivery of our mission to advance the development of nucleic acid therapeutics can only be achieved in collaboration with stakeholders from academia, the NHS, industry, and charity sectors. We are outward-facing, highly collaborative, and take a flexible approach to partnership, ensuring that engaged parties benefit from collaboration while sharing in the intellectual property and patents that arise from our joint work.
We encourage potential collaborators to reach out and explore partnership opportunities. To find out more, please contact us.